Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
9 studies found for:    weill | Open Studies | "Colitis, Ulcerative"
Show Display Options
Rank Status Study
1 Recruiting Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
Condition: Colitis, Ulcerative
Intervention: Drug: PF-06480605
2 Recruiting A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
Condition: Colitis, Ulcerative
Interventions: Drug: Etrolizumab;   Drug: Placebo
3 Recruiting A Study of LY3074828 in Participants With Moderate to Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: LY3074828;   Drug: Placebo
4 Recruiting A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Conditions: Colitis, Ulcerative;   Inflammatory Bowel Diseases
Interventions: Drug: Placebo IV;   Drug: Placebo SC;   Drug: Ustekinumab IV;   Drug: Ustekinumab SC
5 Recruiting A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors
Condition: Ulcerative Colitis
Interventions: Drug: Etrozulimab;   Drug: Placebo
6 Recruiting A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Intervention:
7 Recruiting Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Condition: Ulcerative Colitis
Intervention: Drug: Etrolizumab
8 Recruiting A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
Conditions: Crohn's Disease;   Ulcerative Colitis;   Indeterminate Colitis;   Inflammatory Bowel Diseases
Interventions: Biological: Anti TNF therapy including infliximab;   Drug: No Biologics
9 Recruiting An Efficacy and Safety Study of Infliximab in Pediatric Participants With Inflammatory Bowel Disease
Condition: Inflammatory Bowel Diseases
Intervention: Drug: Infliximab

Study has passed its completion date and status has not been verified in more than two years.